Chester County News and Community Website
Neuronetics, Inc. (NASDAQ: STIM), headquartered in Malvern, PA, is a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders.
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has announced significant updates from major insurers that will broaden access to transcranial magnetic stimulation (TMS) for younger patients. BlueCross BlueShield (BCBS) of …
Expanded Insurance Coverage Boosts Access to TMS Treatment for Adolescents Read More
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced its management team will present at the William Blair 44th Annual Growth Stock Conference. The presentation is scheduled for Thursday, June 6, …
Neuronetics to Present at William Blair Growth Conference Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) this week announced that Humana, a major U.S. health insurer, has updated its coverage policy to include adolescents aged 15-21 in response to …
Humana Pioneers Coverage Expansion for Adolescent Depression Treatment Following FDA Clearance Read More MALVERN, PA — In a recent disclosure, Pennsylvania-based biotech firm Neuronetics (NASDAQ: STIM) announced its first-quarter financial performance for 2024, revealing a promising 12% increase in revenue compared to the …
Neuronetics Boasts 12% Revenue Increase, Expands Depression Treatment Sector Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM), a medical technology firm, awarded Restricted Stock Units (RSUs) equivalent to 55,650 shares of common stock to thirteen newly hired non-executive employees on …
Neuronetics Awards Stock Options to New Employees as Inducement Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has announced that the U.S. Food and Drug Administration (FDA) has cleared NeuroStar TMS (transcranial magnetic stimulation) for use as a first-line add-on …
FDA Clears NeuroStar TMS Therapy for Adolescents with Depression, A First in the Field Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has announced the publication of a groundbreaking study in the prestigious journal Brain Stimulation. The research provides new insights into the effectiveness of …
New Study Offers Hope for Depression Patients Undergoing TMS Therapy Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM), a pioneer in neuroscience-based healthcare solutions, has taken a decisive step to attract and retain top-tier talent by granting inducement awards of Restricted …
Neuronetics Bolsters Talent Pool with Strategic Stock Incentives for New Hires Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced this week that the U.S. Food and Drug Administration (FDA) has granted clearance for its NeuroStar Advanced Therapy system as an adjunct …
FDA Clears NeuroStar’s TMS Therapy for Adolescents with Major Depressive Disorder Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM), a leading name in the field of non-invasive treatments for mental health conditions, has announced a significant expansion of its commercial partnership with …
Neuronetics and Transformations Care Network Join Forces to Expand Availability of Innovative Depression Treatment Read More